Insiders Vertex Pharmaceuticals Incorporated

Equities

VRTX

US92532F1003

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
483 ^USD	-0.51%		+6.08%	+18.72%

Jun. 07	Vertex Pharmaceuticals Says Phase 3 Data Show Trikafta Improves Lung Function in Cystic Fibrosis Patients	MT
Jun. 05	Vertex Pharmaceuticals Insider Sold Shares Worth $1,495,000, According to a Recent SEC Filing	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vertex Pharmaceuticals Insider Sold Shares Worth $1,495,000, According to a Recent SEC Filing	Jun. 05	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,000,500, According to a Recent SEC Filing	Jun. 05	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $2,033,159, According to a Recent SEC Filing	Jun. 03	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,478,068, According to a Recent SEC Filing	May. 31	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $715,205, According to a Recent SEC Filing	May. 29	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $3,168,704, According to a Recent SEC Filing	May. 24	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing	May. 22	MT
Vertex Pharmaceuticals Incorporated Appoints Jennifer Schneider as Independent Director	May. 15	CI
Vertex Pharmaceuticals Insider Sold Shares Worth $2,142,974, According to a Recent SEC Filing	Feb. 27	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $506,546, According to a Recent SEC Filing	Feb. 23	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,519,637, According to a Recent SEC Filing	Feb. 23	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $3,776,528, According to a Recent SEC Filing	Feb. 16	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $727,822, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,804,931, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $383,679, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $1,321,655, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $577,410, According to a Recent SEC Filing	Feb. 13	MT
Vertex Pharmaceuticals Insider Sold Shares Worth $2,785,977, According to a Recent SEC Filing	Jan. 10	MT
Shield Therapeutics hires former Akili leader as new CFO	Jan. 09	AN
Vertex Pharmaceuticals Insider Sold Shares Worth $1,215,000, According to a Recent SEC Filing	Jan. 04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Vertex Pharmaceuticals Incorporated : Vertex and Crispr to market $2.2 million treatment for sickle cell disease

December 11, 2023 at 05:47 am EST